Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury
Status:
Terminated
Trial end date:
2018-07-17
Target enrollment:
Participant gender:
Summary
Back pain is a common secondary condition of both acute and chronic spinal cord injury (SCI).
Current existing treatment including both pharmacologic and non-pharmacologic are limited by
marginal efficacy or intolerable side effects. The purpose of this study is to evaluate the
potential of subcutaneous injections of botulinum toxin A to provide pain relief in spinal
cord injury patients with back pain near the level of injury in the spine. Botulinum toxin A
has been shown in both pre-clinical and clinical studies to help with nerve pain. The
researchers propose a double blinded placebo controlled crossover study to study the effects
of subcutaneous botulinum injections to at--level SCI back pain in patients with spinal cord
injury.
Phase:
Phase 2
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA